SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

09 Feb 2022 Evaluate
Net sales declined -18.55%  to  Rs. 1212.54 million from Rs. 1488.68 millions.Profit after Tax for the quarter ended December 2021 saw a decline of -42.66% from Rs. 183.22 millions to Rs. 105.06  millions.The company reported a degrowth in operating Profit to 294.10 millions from 353.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1212.54 1488.68 -18.55 4589.56 3918.90 17.11 5631.78 4119.47 36.71
Other Income 21.30 8.56 148.83 47.71 25.84 84.64 34.53 51.13 -32.47
PBIDT 294.10 353.27 -16.75 1235.44 821.66 50.36 1245.63 850.33 46.49
Interest 47.52 29.45 61.36 145.35 86.15 68.72 111.62 122.11 -8.59
PBDT 246.58 323.82 -23.85 1090.09 735.51 48.21 1134.01 728.22 55.72
Depreciation 80.96 56.35 43.67 241.81 167.40 44.45 222.82 220.66 0.98
PBT 165.62 267.47 -38.08 848.28 568.11 49.32 911.19 507.56 79.52
TAX 60.56 84.25 -28.12 258.51 180.60 43.14 301.55 180.67 66.91
Deferred Tax 25.56 34.25 -25.37 78.51 75.60 3.85 141.09 91.26 54.60
PAT 105.06 183.22 -42.66 589.77 387.51 52.19 609.64 326.89 86.50
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 24.25 23.73 2.21 26.92 20.97 28.39 22.12 20.64 7.15

SMS Pharmaceuticals Share Price

427.60 3.45 (0.81%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×